Table 1.
Proposed advantages/disadvantages | Characterization of evidence |
---|---|
Reduced injection time | Strongly supportive |
Reduction in endophthalmitis risk | Theoretical |
Reduction in intraocular air bubbles and silicone oil droplets | Theoretical, of possible clinical significance |
Accuracy and precision of intravitreal ranibizumab doses | Supportive |
Disadvantages of a sterile syringe/drug assembly | Theoretical |
Abbreviation: PFS, prefilled syringe.